Dysferlinopathies
- PMID: 21496627
- DOI: 10.1016/B978-0-08-045031-5.00007-4
Dysferlinopathies
Abstract
Dysferlin is a sarcolemmal protein that plays an important role in patching defects in skeletal membrane by regulating vesicle fusion with the sarcolemma. Mutations in the dysferlin gene can lead to a variety of clinical phenotypes. Affected individuals usually present with early involvement of the posterior calf muscles (Miyoshi myopathy) in their teens or early twenties, but can present with proximal greater than distal weakness similar to other limb-girdle muscular dystrophies (LGMD2B), with anterior tibial weakness, an axial myopathy (e.g., rigid spine syndrome or hyperkyphosis resembling bent spine syndrome), or any combination of the above. Muscle biopsies may be quite inflammatory, often resulting in a misdiagnosis as polymyositis. Unfortunately, there are no medical therapies available at this time.
Copyright © 2011 Elsevier B.V. All rights reserved.
Similar articles
-
Intracellular accumulation and reduced sarcolemmal expression of dysferlin in limb--girdle muscular dystrophies.Ann Neurol. 2000 Dec;48(6):902-12. Ann Neurol. 2000. PMID: 11117547
-
Dysferlin mutations in LGMD2B, Miyoshi myopathy, and atypical dysferlinopathies.Hum Mutat. 2005 Aug;26(2):165. doi: 10.1002/humu.9355. Hum Mutat. 2005. PMID: 16010686
-
Pattern of skeletal muscle involvement in primary dysferlinopathies: a whole-body 3.0-T magnetic resonance imaging study.Acta Neurol Scand. 2009 Aug;120(2):111-8. doi: 10.1111/j.1600-0404.2008.01129.x. Epub 2008 Dec 22. Acta Neurol Scand. 2009. PMID: 19154541
-
Dysferlinopathies: Clinical and genetic variability.Clin Genet. 2022 Dec;102(6):465-473. doi: 10.1111/cge.14216. Epub 2022 Sep 6. Clin Genet. 2022. PMID: 36029111 Review.
-
Dysferlinopathies.Neurol India. 2008 Jul-Sep;56(3):289-97. doi: 10.4103/0028-3886.43447. Neurol India. 2008. PMID: 18974555 Review.
Cited by
-
Three-dimensional mechanical characterization of murine skeletal muscle using quantitative micro-elastography.Biomed Opt Express. 2022 Oct 17;13(11):5879-5899. doi: 10.1364/BOE.471062. eCollection 2022 Nov 1. Biomed Opt Express. 2022. PMID: 36733728 Free PMC article.
-
Pharmacotherapeutic Approaches to Treatment of Muscular Dystrophies.Biomolecules. 2023 Oct 17;13(10):1536. doi: 10.3390/biom13101536. Biomolecules. 2023. PMID: 37892218 Free PMC article. Review.
-
Clinical Presentation, Diagnosis, and Genetic Insights of Miyoshi Myopathy: A Case Report and Literature Review.Cureus. 2024 Sep 7;16(9):e68869. doi: 10.7759/cureus.68869. eCollection 2024 Sep. Cureus. 2024. PMID: 39376872 Free PMC article.
-
Elevated Ca2+ at the triad junction underlies dysregulation of Ca2+ signaling in dysferlin-null skeletal muscle.Front Physiol. 2022 Nov 3;13:1032447. doi: 10.3389/fphys.2022.1032447. eCollection 2022. Front Physiol. 2022. PMID: 36406982 Free PMC article.
-
Triadopathies: an emerging class of skeletal muscle diseases.Neurotherapeutics. 2014 Oct;11(4):773-85. doi: 10.1007/s13311-014-0300-3. Neurotherapeutics. 2014. PMID: 25168790 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical